Siegal T - Search Results

1

MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma.

Pillar N, Bairey O, Goldschmidt N, Fellig Y, Rosenblat Y, Shehtman I, Haguel D, Raanani P, Shomron N, Siegal T. Pillar N, et al. Among authors: siegal t. Oncotarget. 2017 Sep 15;8(49):86020-86030. doi: 10.18632/oncotarget.20902. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156774 Free PMC article.

2

High incidence of thromboembolism in patients with central nervous system lymphoma.

Goldschmidt N, Linetsky E, Shalom E, Varon D, Siegal T. Goldschmidt N, et al. Among authors: siegal t. Cancer. 2003 Sep 15;98(6):1239-42. doi: 10.1002/cncr.11623. Cancer. 2003. PMID: 12973848 Free article.

3

Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression.

Levin N, Lavon I, Zelikovitsh B, Fuchs D, Bokstein F, Fellig Y, Siegal T. Levin N, et al. Among authors: siegal t. Cancer. 2006 Apr 15;106(8):1759-65. doi: 10.1002/cncr.21809. Cancer. 2006. PMID: 16541434 Free article.

4

Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.

Lavon I, Zrihan D, Zelikovitch B, Fellig Y, Fuchs D, Soffer D, Siegal T. Lavon I, et al. Among authors: siegal t. Clin Cancer Res. 2007 Mar 1;13(5):1429-37. doi: 10.1158/1078-0432.CCR-06-2050. Clin Cancer Res. 2007. PMID: 17332285

5

Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.

Lavon I, Fuchs D, Zrihan D, Efroni G, Zelikovitch B, Fellig Y, Siegal T. Lavon I, et al. Among authors: siegal t. Cancer Res. 2007 Sep 15;67(18):8952-9. doi: 10.1158/0008-5472.CAN-06-3820. Cancer Res. 2007. PMID: 17875738

6

CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?

Siegal T, Goldschmidt N. Siegal T, et al. Blood Rev. 2012 May;26(3):97-106. doi: 10.1016/j.blre.2011.12.001. Epub 2012 Jan 13. Blood Rev. 2012. PMID: 22244544 Review.

7

The possible role of maintenance treatment for primary central nervous system lymphoma.

Bairey O, Siegal T. Bairey O, et al. Among authors: siegal t. Blood Rev. 2018 Sep;32(5):378-386. doi: 10.1016/j.blre.2018.03.003. Epub 2018 Mar 11. Blood Rev. 2018. PMID: 29551465 Review.

8

Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.

Shargian-Alon L, Raanani P, Rozovski U, Siegal T, Yust-Katz S, Yeshurun M. Shargian-Alon L, et al. Among authors: siegal t. Acta Haematol. 2019;141(1):19-22. doi: 10.1159/000494423. Epub 2018 Nov 15. Acta Haematol. 2019. PMID: 30439710

9

Primary CNS Lymphoma in the Elderly: The Challenge.

Siegal T, Bairey O. Siegal T, et al. Acta Haematol. 2019;141(3):138-145. doi: 10.1159/000495284. Epub 2019 Feb 15. Acta Haematol. 2019. PMID: 30783026 Review.

10

Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?

Bairey O, Shargian-Alon L, Siegal T. Bairey O, et al. Among authors: siegal t. Acta Haematol. 2021;144(4):389-402. doi: 10.1159/000511208. Epub 2020 Nov 26. Acta Haematol. 2021. PMID: 33242855 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters